Harm Reduction’s Road From Fringe to Federal Drug Policy
The overdose crisis in the U.S. is as deadly as it’s ever been. In response, the Biden administration is embracing a controversial strategy known as harm reduction, which seeks to keep drug users safe even as they continue using. We explore how harm reduction has become more mainstream and what kind of impact we can expect it to have on the overdose crisis.
Ricky Bluthenthal, PhD, Associate Dean for Social Justice; Keck School of Medicine, University of Southern California
Keith Humphreys, PhD, Esther Ting Memorial Professor of Psychiatry and Behavioral Services, Stanford University
Beau Kilmer, PhD, Director of the RAND Drug Policy Research Center
Kimberly Sue, MD, PhD, Assistant Professor of Medicine, Yale School of Medicine
Maia Szalavitz, Journalist and Author, Undoing Drugs: The Untold Story of Harm Reduction and the Future of Addiction
Read a full transcript and dig deeper into the issues explored in today’s episode on our website.
Please take a couple of minutes to help us learn more about you by filling out our listener survey.
Support this type of journalism today by making a donation.
Sign up for our weekly newsletter to see what research health policy experts are reading right now.
Follow us on Twitter.
See acast.com/privacy for privacy and opt-out information.